Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 for Antimicrobial Peptide Expression in Atopic Dermatitis and Psoriasis
NCT00789880Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2008
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d in atopic dermatitis (AD), psoriasis, sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2008; status: completed.
02
Drugs
vitamin d
03
Conditions
atopic dermatitis (AD)psoriasis
Beyond the preview
Go deeper on NCT00789880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789880.